Similar articles

• Therapeutic transfer of DNA encoding adenoviral E1A.

  Deissler H, Opalka B. Deissler H, et al. Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):1-10. doi: 10.2174/157489207779561471. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221050 Review.
• The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A.

  Yu D, Hung MC. Yu D, et al. Cancer Metastasis Rev. 1998 Jun;17(2):195-202. doi: 10.1023/a:1006054421970. Cancer Metastasis Rev. 1998. PMID: 9770116 Review. No abstract available.
• A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.

  Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S, Yoshida R, Uno F, Mizuguchi H, Ohtsuru A, Urata Y, Kagawa S, Fujiwara T. Yamasaki Y, et al. Eur J Cancer. 2012 Sep;48(14):2282-91. doi: 10.1016/j.ejca.2011.12.020. Epub 2012 Jan 13. Eur J Cancer. 2012. PMID: 22244827
• Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.

  Sauthoff H, Pipiya T, Heitner S, Chen S, Bleck B, Reibman J, Chang W, Norman RG, Rom WN, Hay JG. Sauthoff H, et al. Mol Ther. 2004 Oct;10(4):749-57. doi: 10.1016/j.ymthe.2004.07.014. Mol Ther. 2004. PMID: 15451459
• Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.

  Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC. Yu D, et al. Oncogene. 1995 Oct 5;11(7):1383-8. Oncogene. 1995. PMID: 7478560